Seva Foundation contributes to report that shows 90% of vision impairment can be treated with existing, cost-effective interventions.

According to a report, the blood glucose monitoring device market is anticipated to reach over USD 2.61 billion by 2026 driven by growing inclination for home care diagnosis and rising need for real-time data along with numerous technological advancements.